
Cyclosporine: A strong oral immune-suppressing drug used in short bursts for severe eczema and psoriasis. It works faster than anything else, and blood pressure and kidney function set a hard limit on how long anyone stays on it. Desonide: A low-potency prescription steroid made for delicate skin. It is the usual step up from hydrocortisone for the face, the folds and young children.


Choose for a fast, short burst of control in severe eczema or psoriasis while a longer-term treatment is set up.
Choose as the step up from hydrocortisone for delicate skin — face, eyelids, folds and babies.
Can you take them together?
Desonide can be used on the face or folds during a cyclosporine course. They do not interact.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Inhibits calcineurin: Binds cyclophilin to block a T-cell activation switch. Reduces IL-2 signals: Limits a messenger that helps T cells become active. Calms skin inflammation: Overactive immune responses in skin decrease.
Cyclosporine binds cyclophilin; that complex inhibits calcineurin and T-cell cytokine production. This is a simplified skin-focused explanation of systemic immunosuppression.

Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.
The dose is set by body weight, then adjusted by blood pressure and kidney tests, not by how the skin looks.
Starting dose: About 2.5 mg per kilogram of body weight a day, split into two doses. A severe flare may start around 4 to 5 mg per kilogram a day to get control quickly.
Going up: Raised in small steps every two to four weeks if response is poor, and only if the tests are stable.
Coming down: Once the skin is calm, the dose comes down in stages, to give the next treatment time to work.
Total course: Short by design. Many courses run 8 to 16 weeks. Guidelines advise no more than about a year of continuous treatment, less where possible.
When to Apply: Twice a day on the affected skin only, in a thin film. One fingertip unit, the amount along the last joint of an adult index finger, covers about two adult palms. Moisturizer goes on separately and continues after the course ends.
How to Start: Twice daily from day one until the rash is flat, not just calmer, usually one to two weeks. Two weeks is the usual limit on a face, up to four weeks on the body before review. In children, follow the prescriber's duration, not the size of the tube.
If It Irritates: Stinging is usually the base, not the drug, and likelier on broken skin or with an alcohol-containing gel or foam. The ointment settles it. Redness or itch that worsens over a week or two can be allergy to the steroid or a preservative, and needs a different product.
If It Is Not Working: Two weeks of proper twice-daily use is a fair test. If nothing changed, question the diagnosis, look for infection, and ask whether the site can take a stronger steroid. On thin skin the better next step is often a non-steroid such as tacrolimus.
Twice a day, about 12 hours apart, at the same times daily. Be consistent about food: always with meals or always without, because switching changes absorption. Swallow capsules whole and leave them in the foil until you take them.
On the liquid, mix it with orange or apple juice in a glass cup, stir and drink it straight away, then rinse the cup with more juice and drink that too. Never use grapefruit juice.
Take it when you remember unless the next dose is close, then skip it. Never take two at once. Tell the prescriber if you miss more than a dose or two, or vomit soon after taking it, because the dose is built around your blood level.
Cyclosporine is monitored more closely than any other skin drug, and that monitoring is why it can be used at all. Blood pressure is measured at every visit, often at home. Kidney function is checked by blood test, twice before starting for a reliable baseline, then every couple of weeks for a month or two, then monthly once the dose is steady. The same draws cover potassium, magnesium, uric acid, liver enzymes, blood counts and cholesterol. Drug blood levels are routine in transplant care, not usually needed at dermatology doses.
Two numbers drive the decisions. A rise in creatinine of about a quarter above your baseline, confirmed on a repeat test, means dropping the dose; about half means stopping. New high blood pressure means lowering the dose or adding a blood pressure medicine, and the choice matters: diltiazem and verapamil push levels up, amlodipine does not.
The interaction list is long. Drugs that raise levels include the azole antifungals, clarithromycin and erythromycin, and some HIV and hepatitis C medicines. Drugs that lower it include rifampin, phenytoin, carbamazepine and St John's wort. It also raises statin levels, so that dose is often reduced, and it interacts with colchicine, digoxin, methotrexate and potassium-sparing water tablets. Bring every prescription, supplement and herbal product to the first visit.
The time limit is the point of all this. Kidney damage builds with continuous use and part of it can be permanent, so guidelines cap continuous treatment at about a year and most dermatology courses are far shorter. Long or repeated use also raises the risk of skin cancer, lymphoma and serious infection, so skin checks continue afterward.
No blood tests for a standard course in a healthy person. Monitoring is looking at the skin: did the rash clear, has the skin become thin or shiny, have small vessels or stretch marks appeared in the folds.
Children are watched more closely, not because desonide is dangerous but because they absorb proportionally more for their size. Prescribers watch how much is used per month, and whether a repeat pattern has quietly become daily use.
Low potency does not mean indefinite. Where a condition keeps flaring, the plan is short courses on flares with emollients doing the daily work, or a switch to a non-steroid such as tacrolimus or pimecrolimus for the face and folds. Around the eyes, prolonged steroid use of any potency raises the risk of glaucoma and cataract.
Approximate windows, not promises.
First 2 weeksStarting: Itch settles first, often within days, and sleep improves. Tingling or burning in the hands and feet, headache and mild nausea are common early. Blood pressure and kidney tests get checked.
Weeks 2 to 6Working: Redness, weeping and thickness improve clearly. Chronic hives that antihistamines do not control usually settle within a month. Extra hair growth on the face, arms and body and swollen or tender gums start now; both are dose-related and reverse after stopping.
Weeks 8 to 16Plaque psoriasis: Large improvement, often near-clear at the higher end of the dose range. Usually where the course ends and another treatment takes over.
VariableSevere inflammatory ulcers: In pyoderma gangrenosum it stops the ulcer spreading while healing catches up. Response times differ a lot.
ThroughoutThe tests: Blood pressure creeping up and kidney numbers drifting decide whether the dose drops or the drug stops. Neither causes symptoms, which is why the tests are not optional.
First few minutesApplying it: A thin layer on the affected skin. Low potency, which suits the face, the eyelids and small children.
Days 1 to 3Itch first: Itching and stinging settle before the rash looks different, which is often what lets a child sleep.
Days 3 to 10Clearing: Redness fades and rough or weeping skin settles. Most facial flares are largely better here.
Weeks 1 to 2Judge it here: On the face, stop and reassess here. Facial and eyelid eczema settle without the thinning risk a stronger steroid carries, and seborrheic dermatitis improves in the same window.
Weeks 2 to 4Folds and the body: Intertrigo and fold rashes respond, and the mildness suits a site that absorbs heavily; any yeast needs treating too. On the body, about four weeks before review.
After stoppingMarks stay behind: Brown or gray patches where the rash was are pigment change, not scarring, and fade over weeks to months.
Sorted by what to do about them.
Generic capsules are cheap next to biologics, part of why the drug is still used. Branded versions cost more without working better.
The visible cost is not the whole cost. Repeated blood tests, blood pressure checks and appointments add up, and none are optional. It is cheaper per month than a biologic but taken for only a few months, so the comparison depends on what comes after.
Insurance generally covers it for severe psoriasis. Eczema coverage varies more in the United States, where that use is off-label.
Generic desonide cream, ointment and lotion are cheap and well covered. The branded gel and foam, easier to use on faces and hairy areas, cost considerably more, and plans often ask for a generic first.
It costs more than over-the-counter hydrocortisone, which needs no visit, and less than non-steroids like tacrolimus or crisaborole. If cost is a barrier, start with the cream or ointment.
Faster than anything else for these conditions. Itch improves within days, clearing by four to six weeks.
Most courses run months. Guidelines cap continuous use at about one year, because kidney effects build and some can be permanent.
It raises blood pressure in a meaningful share of people, and that causes no symptoms. Catching it early usually means lowering the dose rather than stopping.
No. Grapefruit, pomelo and Seville oranges block the enzyme that clears it, so levels rise unpredictably. Other citrus is fine.
Both are dose-related. Not dangerous, usually better if the dose comes down, and gone after stopping.
Usually, within weeks to a few months, unless another treatment is running. Planning that before the taper is the point of the short course.
Yes, by a step or two, and both are low potency. Well below mid-potency steroids like triamcinolone.
That is largely what it is for. Keep courses to about two weeks and stop once the rash is flat. Repeated face use is a reason to ask about a non-steroid.
A common choice in children, and some formulations are approved from a few months of age. Follow the prescriber's duration, and remember a diaper acts as a dressing.
A short course at this potency is unlikely to. Thinning comes from stronger steroids, thin sites and long use. Untreated eczema has its own costs: months of scratching and more pigment change.
It can, less readily than stronger steroids. Pale patches show more on deeper skin tones and recover slowly. Untreated inflammation also leaves light and dark marks.
Several steps of potency. Triamcinolone on a face or in a fold for two weeks can cause thinning and stretch marks desonide would not. Matching steroid to site is why both exist.